Chronic Low-back Pain (cLBP)BACK-FITNCT07475481
Exercise-Based Strategies for Chronic Back Pain
A study testing Gym settings, Physio settings and Home - based settings: exercises based on developmental positions in people with Chronic Low-back Pain (cLBP), run by Charles University, Czech Republic at 1 site in Czechia.
Trial summary
This randomized, controlled, five-arm, parallel-group trial will evaluate the effects of 8 weeks of supervised resistance training and developmental position-based exercise, with or without real-time non-invasive intra-abdominal pressure biofeedback, in adults aged 40 to 60 years with chronic low back pain. Read more about this study
- Who is it for?
- Ages 40 to 60 years
- Conditions the study is for
- Chronic Low-back Pain (cLBP)
- What is being tested?
- Gym settings, Physio settings and Home - based settings: exercises based on developmental positions
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteCzechia
- Study dates
- 1 Jul 2027to 31 Mar 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Chronic low back pain lasting more than 12 weeks, with current low back pain at screening/baseline.
- Resting blood pressure below 139/89 mmHg.
- Health status allowing participation in moderate-intensity resistance training and aerobic activity.
- Physically active, but not professional athletes.
- Non-smoker.
- Able and willing to provide written informed consent and comply with study procedures
Who cannot join
- Absolute or relative contraindications to resistance training or other clinically relevant cardiovascular contraindications.
- Coronary artery disease, heart rhythm disorders, acute myocarditis, Marfan syndrome, or other cardiovascular conditions judged unsafe by the study physician.
- History of myocardial infarction, cerebrovascular disease, peripheral vascular disease, or grade II-IV hypertension.
- Type 1 or type 2 diabetes mellitus.
- Severe obesity (BMI >= 40.0 kg/m2).
- Infectious disease at screening (for example, COVID-19 or influenza).
Show all 12Show fewer
- Current treatment for chronic low back pain from another healthcare provider.
- Prior spine surgery or lower-limb surgery.
- Structural spinal deformity such as spondylolisthesis or spondylolysis.
- Spinal fracture, inflammatory spinal disorder, or neurological signs of nerve root compromise, including decreased tendon reflexes, sensory loss, or motor deficits.
- Dizziness during exercise.
- Use of medications other than analgesics and non-steroidal anti-inflammatory drugs, unless specifically approved by the study physician.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Czechia1 site
Faculty of Physical Education and Sport, Chrales University
Prague, 162 52
Roman Jurik, Ph.D., +420 775 218 277, roman.jurik@ftvs.cuni.cz
About this study
Official title: Innovative Exercise-Based Strategies for Managing Chronic Back Pain: A Multisystem Health Approach
This randomized, controlled, five-arm, parallel-group trial will evaluate the effects of 8 weeks of supervised resistance training and developmental position-based exercise, with or without real-time non-invasive intra-abdominal pressure biofeedback, in adults aged 40 to 60 years with chronic low back pain. The trial will compare supervised gym-based agonist-antagonist paired set resistance training with OHMTRACK, supervised gym-based resistance training without OHMTRACK, supervised physiotherapy-based developmental exercise with OHMTRACK, home-based developmental exercise with OHMTRACK, and an active control condition. Primary outcomes will assess changes in pain and physical function after the intervention. Secondary outcomes will include neuromuscular coordination, postural stabilization, cardiovascular, respiratory, metabolic, behavioral, feasibility, and follow-up outcomes.
Read the detailed description
Chronic low back pain is a prevalent and multifactorial condition associated with impaired physical function, reduced quality of life, and substantial socioeconomic burden. Exercise therapy, especially resistance training, is an important non-pharmacological treatment strategy, but the integration of exercise with real-time monitoring of intra-abdominal pressure remains underexplored. This study will examine whether combining exercise with non-invasive intra-abdominal pressure biofeedback can improve trunk stabilization, movement control, pain, and broader health outcomes.
The trial includes a 2-week familiarization phase, an 8-week intervention phase, and an 8-week post-intervention follow-up without structured exercise. Participants will be randomly assigned in a 1:1:1:1:1 ratio to one of five parallel groups. The supervised gym-based program uses full-body agonist-antagonist paired set resistance training twice weekly for 60 minutes, with three sets of 10 repetitions at 75 percent of one-repetition maximum, 90-second rest intervals, and a 3-0-2-1 tempo. The supervised physiotherapy and home-based arms use developmental position-based exercise emphasizing trunk stabilization, breathing coordination, support, and movement quality. OHMTRACK biofeedback will be used in selected groups to support real-time regulation of intra-abdominal pressure.
Outcome measures will cover pain, trunk muscle function, postural stabilization, body composition, cardiovascular health, respiratory function, metabolic health, strength, functional capacity, adherence, behavioral regulation, and adverse events. Measurements are scheduled at baseline, during the intervention, and through follow-up to examine both immediate and retained effects.
- Conditions
- Chronic Low-back Pain (cLBP)
- Being tested
- Gym settings, Physio settings, Home - based settings: exercises based on developmental positions, Home - based settings: Usual activity monitoring
- Keywords
- chronic low back pain, resistance training, exercise therapy, dynamic neuromuscular stabilization, developmental positions, intra-abdominal pressure, rehabilitation, postural stabilization
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Gym settingsBehavioural
Also called Agonist-antagonist paired set resistance training with OHMTRACK
An 8-week supervised full-body resistance training program preceded by a 2-week familiarization phase (4 sessions). During the intervention phase, participants perform training twice weekly for 60 minutes per session. Each session includes a 10-minute warm-up, 40-minute main phase, and 10-minute cool-down. The program consists of 3 sets of 10 repetitions at 75% of 1RM, 90-second rest intervals, and a 3-0-2-1 movement tempo. Training is delivered in a gym setting under professional supervision. Resistance training with or without real-time OHMTRACK biofeedback monitor which support breathing mechanics and trunk stabilization.
Physio settingsBehavioural
An 8-week supervised exercise program based on developmental positions and neurophysiological principles, preceded by a 2-week familiarization phase (4 sessions). Participants exercise twice weekly for 60 minutes per session under physiotherapist supervision. Sessions focus on breathing coordination, deep trunk stabilization, postural control, support function, and movement quality using structured developmental movement sequences.
Home - based settings: exercises based on developmental positionsBehavioural
Also called Exercises based on developmental positions
An 8-week home-based exercise program based on developmental positions and neurophysiological principles, preceded by a 2-week familiarization phase (4 sessions). Participants perform exercises twice weekly for 60 minutes per session using electronic manuals and video instructions. The program emphasizes breathing coordination, deep trunk stabilization, postural control, and self-correction of movement quality in an unsupervised home setting, with the possibility of contacting the research team for support.
Home - based settings: Usual activity monitoringBehavioural
Also called Usual activity monitoring
Participants continue their usual daily activities without participating in a structured resistance training or developmental position exercise program. Physical activity is monitored throughout the study using a wearable activity tracker to record daily step counts and overall movement behavior.
| Study group | Role | What they receive |
|---|---|---|
| Supervised resistance training with OHMTRACK | Experimental | Participants complete a 2-week supervised familiarization phase followed by 8 weeks of supervised full-body agonist-antagonist paired set resistance training twice weekly for 60 minutes in the gym setting. Training load is based on 75 percent of 1RM, with three sets of 10 repetitions, 90-second rest intervals, and a 3-0-2-1 tempo. Real-time OHMTRACK biofeedback is used to support breathing mechanics and trunk stabilization. Receives: Behavioral: Gym settings |
| Supervised resistance training without OHMTRACK | Experimental | Participants complete the same supervised gym-based resistance training program as the OHMTRACK resistance training arm, but without real-time intra-abdominal pressure biofeedback. Receives: Behavioral: Gym settings |
| Supervised EDP with OHMTRACK | Experimental | Participants complete a 2-week supervised familiarization phase followed by 8 weeks of supervised developmental position-based exercise twice weekly for 60 minutes in the physiotherapy setting. Sessions emphasize movement quality, breathing coordination, support, movement phases, deep trunk stabilization, and real-time intra-abdominal pressure regulation. Receives: Behavioral: Physio settings |
| Home-based EDP with OHMTRACK | Experimental | Participants complete a 2-week familiarization phase using electronic instructions, manuals, and video recordings, followed by 8 weeks of home-based developmental position-based exercise twice weekly for 60 minutes. Participants may contact the research team with questions. Real-time OHMTRACK biofeedback is used to support self-correction and breathing coordination. Receives: Behavioral: Home - based settings: exercises based on developmental positions |
| Active control | Active comparator | Proposed wording based on the source protocol: participants continue their usual daily activities and wear a Fitbit Inspire 2 for step monitoring, without a structured resistance training or developmental exercise program. This description should be confirmed or replaced if the control condition includes additional procedures. Receives: Behavioral: Home - based settings: Usual activity monitoring |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Trunk Flexor and Extensor Muscle Function
Trunk Flexor Muscle Strength (Isokinetic Peak Torque): Trunk flexor muscle function will be assessed using an isokinetic dynamometer (Cybex NORM or HUMAC NORM system). The primary outcome will be peak torque during trunk flexion, reported in Newton-meters (N·m) (and, if applicable, normalized to body mass as N·m/kg). Higher values indicate greater trunk flexor strength.
Trunk Extensor Muscle Strength (Isokinetic Peak Torque): Trunk extensor muscle function will be assessed using an isokinetic dynamometer (Cybex NORM or HUMAC NORM system). The primary outcome will be peak torque during trunk extension, reported in N·m (and, if applicable, normalized to body mass as N·m/kg). Higher values indicate greater trunk extensor strength.
Measured: Baseline, Week 8, Week 12, and Week 16
Short-Form McGill Pain Questionnaire (SF-MPQ) Total Score
Pain intensity and pain-related characteristics will be assessed using the Short-Form McGill Pain Questionnaire (SF-MPQ). The outcome will be the SF-MPQ total score, calculated as the sum of 15 descriptor items rated on a 0-3 scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). Total score ranges from 0 to 45 points, with higher scores indicating worse pain and lower scores indicating improvement.
Measured: Baseline to Week 16 (1x every week)
Change in DNS-Based Functional Postural Stabilization Performance
Abdominal wall tension will be measured during the performance of standardized DNS functional tests using a wearable abdominal wall tension monitoring belt (OHMBelt). The device provides continuous, noninvasive, device-derived estimates of abdominal wall tension, which are related to changes in intra-abdominal pressure. Outcomes will include peak abdominal wall tension and mean abdominal wall tension recorded during each DNS test, reported in device-derived units (arbitrary units, a.u.) (and/or as change from baseline, as applicable). Higher values indicate greater abdominal wall tension during task performance.
Measured: Baseline, Week 8, Week 12, and Week 16
Secondary outcomes (18)
Maximal Oxygen Uptake (VO2max) During Treadmill Graded Exercise Test
Maximal oxygen uptake (VO₂max) will be assessed using a graded exercise test (GXT) on a motorized treadmill with breath-by-breath gas exchange analysis (Metalyzer metabolic cart). VO₂max will be defined as the highest 30-second averaged oxygen uptake achieved during the test and reported in mL/kg/min (and, if applicable, also in L/min). Higher VO₂max values indicate greater aerobic capacity.
Measured: Baseline, Week 8, Week 12, and Week 16
Quantitative Sensory Testing - Pressure Pain Threshold
Pressure pain threshold will be assessed using quantitative sensory testing with a handheld digital pressure algometer applied at standardized anatomical sites. The outcome will be reported as the pressure at pain threshold in kilopascals (kPa). Higher PPT values indicate lower mechanical pain sensitivity.
Measured: Baseline, Week 8, Week 12, and Week 16
Isometric Mid-Thigh Pull
Lower-body maximal isometric force production will be assessed using an isometric mid-thigh pull (IMTP) performed on dual force plates (ForceDecks system). The primary outcome will be peak vertical ground reaction force, reported in Newtons (N) (and, if applicable, also normalized to body mass as N/kg). Higher values indicate greater maximal isometric lower-body force.
Measured: Baseline, Week 8, Week 12, and Week 16
Handgrip Strength
Handgrip (kg) is measured by Takei (TKK 5401, Japan).It will be measured for both hands (left and right). Three trials will be performed on each hand and the mean will be calculated. The standard for men over 40 years of age is 47 (±9.5) kg for the right hand and 45 (±9.3) kg for the left hand. The standard for women over 40 is 29 (±5.7) kg for the right hand and 28 (±5.7) kg for the left hand. Higher values are considered to be better.
Measured: Baseline, Week 8, Week 12, and Week 16
Behavioral Regulation in Exercise Questionnaire (BREQ-3) Subscale Scores
Exercise motivation and self-regulation will be assessed using the Behavioral Regulation in Exercise Questionnaire-3 (BREQ-3). Items are rated on a 0-4 scale (0 = not true for me, 4 = very true for me). Outcomes will be reported as subscale mean scores (range 0-4 points). Higher scores indicate greater endorsement of the respective motivation/self-regulation construct.
Measured: Baseline and Week 8
Adverse Events (AEs) and Serious Adverse Events (SAEs)
Adverse events will be monitored and recorded throughout the intervention period. Events of interest include falls, injuries, musculoskeletal complaints, hypoglycemic episodes, major cardiovascular events, and any other events potentially related to study participation.
Adverse events will be captured via participant self-report at each weekly contact/session and active investigator monitoring. Each event will be documented by type, onset date, duration, severity (mild/moderate/severe), seriousness (serious vs non-serious), and relatedness to the study intervention (not related/possibly/probably/definitely related). Outcomes will be reported as the number of participants experiencing ≥1 adverse event and the total number of adverse events during the intervention.
Measured: Throughout the intervention period, Weeks 1-8 (every week)
Body Mass Index (BMI)
Body mass index (BMI) will be calculated as body weight in kilograms (kg) divided by height in meters squared (m²) and reported in kg/m². Higher BMI indicates higher body mass relative to height. The World Health Organization (WHO) adult reference range for normal BMI is 18.5-24.9 kg/m².
Measured: Baseline, Week 8, Week 12, and Week 16
Total Body Fat Mass
Total body fat mass will be assessed using dual-energy X-ray absorptiometry (DEXA) and/or InBody370S and reported in kilograms (kg).
Measured: Baseline, Week 8, Week 12, and Week 16
Lean mass
Total body lean mass will be assessed using dual-energy X-ray absorptiometry (DEXA) and/or InBody370S and reported in kilograms (kg).
Measured: Baseline, Week 8, Week 12, and Week 16
Body Weight
Body weight will be measured using a InBody370S and reported in kilograms (kg).
Measured: Baseline, Week 8, Week 12, and Week 16
Serum Total Cholesterol Concentration
Serum total cholesterol will be measured from venous blood samples using standard clinical laboratory enzymatic assays. Results will be reported in mmol/L. Laboratory-specific reference ranges will be used for clinical interpretation (e.g., 2.90-5.00 mmol/L).
Measured: Baseline, Week 8, Week 12, and Week 16
Serum Low-Density Lipoprotein (LDL) Cholesterol Concentration
Serum LDL cholesterol will be measured from venous blood samples using standard clinical laboratory assays. Results will be reported in mmol/L. Laboratory-specific reference ranges will be used for clinical interpretation (e.g., 1.20-3.00 mmol/L).
Measured: Baseline, Week 8, Week 12, and Week 16
Serum High-Density Lipoprotein (HDL) Cholesterol Concentration
Serum HDL cholesterol will be measured from venous blood samples using standard clinical laboratory assays. Results will be reported in mmol/L. Laboratory-specific reference ranges will be used for clinical interpretation (e.g., 1.00-2.10 mmol/L).
Measured: Baseline, Week 8, Week 12, and Week 16
Fasting Blood Glucose Concentration
Fasting blood glucose will be measured from venous blood samples using standard clinical laboratory assays (e.g., enzymatic methods). Results will be reported in mmol/L. Laboratory-specific reference ranges will be used for clinical interpretation (e.g., 3.30-5.59 mmol/L).
Measured: Baseline, Week 8, Week 12, and Week 16
Systolic Blood Pressure (SBP)
Systolic blood pressure (SBP) will be assessed in a seated resting position using a validated oscillometric device with brachial cuff-based measurement (Arteriograph). Results will be reported in millimeters of mercury (mmHg). Higher values indicate higher systolic arterial pressure. For clinical interpretation, commonly used resting thresholds include <120 mmHg (normal) and ≥140 mmHg (hypertension) (thresholds may vary by guideline and population).
Measured: Baseline, Week 8, Week 12, and Week 16
Diastolic Blood Pressure (DBP)
Diastolic blood pressure (DBP) will be assessed in a seated resting position using a validated oscillometric device with brachial cuff-based measurement (Arteriograph). Results will be reported in mmHg. Higher values indicate higher diastolic arterial pressure. For clinical interpretation, commonly used resting thresholds include <80 mmHg (normal) and ≥90 mmHg (hypertension) (thresholds may vary by guideline and population).
Measured: Baseline, Week 8, Week 12, and Week 16
Aortic Pulse Wave Velocity (aPWV)
Aortic pulse wave velocity (aPWV) will be assessed using oscillometric pulse wave analysis with a brachial cuff-based system (Arteriograph). Results will be reported in meters per second (m/s). Higher aPWV values indicate greater arterial stiffness. For clinical interpretation, ~10 m/s is commonly used as a threshold indicating increased arterial stiffness in adults, although reference values vary by age and blood pressure.
Measured: Baseline, Week 8, Week 12, and Week 16
Resting Heart Rate (RHR)
Resting heart rate will be assessed during seated rest using a cuff-based oscillometric measurement (Arteriograph). Results will be reported in beats per minute (bpm). Higher values indicate higher resting heart rate. In adults, a commonly cited resting reference range is approximately 60-100 bpm (may vary with fitness level, medications, and clinical status).
Measured: Baseline, Week 8, Week 12, and Week 16
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Mar 2026
- Study start1 Jul 2027 (estimated)
- Primary completion31 Mar 2028 (estimated)
- Study completion31 Mar 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Low-back Pain (cLBP)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Five parallel groups: supervised resistance training with OHMTRACK, supervised resistance training without OHMTRACK, supervised EDP with OHMTRACK, home-based EDP with OHMTRACK, and active control.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Charles University, Czech Republic
- Sponsor type
- University, hospital or other
- Collaborators
- The Jerzy Kukuczka Academy of Physical Education in Katowice
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07475481
- Sponsor's protocol ID
- 095/2025
- Acronym
- BACK-FIT
- Status last verified
- Mar 2026
- First submitted
- 5 Mar 2026
- Last updated
- 16 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 16 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Innovative Exercise-Based Strategies for Managing Chronic Back Pain: A Multisystem Health Approach
- ClinicalTrials.gov ID
- NCT07475481
- Acronym / sponsor ID
- BACK-FIT / 095/2025
- Conditions
- Chronic Low-back Pain (cLBP)
- Keywords
- chronic low back pain, resistance training, exercise therapy, dynamic neuromuscular stabilization, developmental positions, intra-abdominal pressure, rehabilitation, postural stabilization
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Charles University, Czech RepublicUniversity, hospital or other
- Collaborators
- The Jerzy Kukuczka Academy of Physical Education in Katowice
- Study start
- 1 Jul 2027 (estimated)
- Primary completion
- 31 Mar 2028 (estimated)
- Study completion
- 31 Mar 2030 (estimated)
- First posted
- 16 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized, controlled, five-arm, parallel-group trial will evaluate the effects of 8 weeks of supervised resistance training and developmental position-based exercise, with or without real-time non-invasive intra-abdominal pressure biofeedback, in adults aged 40 to 60 years with chronic low back pain. The trial will compare supervised gym-based agonist-antagonist paired set resistance training with OHMTRACK, supervised gym-based resistance training without OHMTRACK, supervised physiotherapy-based developmental exercise with OHMTRACK, home-based developmental exercise with OHMTRACK, and an active control condition. Primary outcomes will assess changes in pain and physical function after the intervention. Secondary outcomes will include neuromuscular coordination, postural stabilization, cardiovascular, respiratory, metabolic, behavioral, feasibility, and follow-up outcomes.
Detailed description
Chronic low back pain is a prevalent and multifactorial condition associated with impaired physical function, reduced quality of life, and substantial socioeconomic burden. Exercise therapy, especially resistance training, is an important non-pharmacological treatment strategy, but the integration of exercise with real-time monitoring of intra-abdominal pressure remains underexplored. This study will examine whether combining exercise with non-invasive intra-abdominal pressure biofeedback can improve trunk stabilization, movement control, pain, and broader health outcomes.
The trial includes a 2-week familiarization phase, an 8-week intervention phase, and an 8-week post-intervention follow-up without structured exercise. Participants will be randomly assigned in a 1:1:1:1:1 ratio to one of five parallel groups. The supervised gym-based program uses full-body agonist-antagonist paired set resistance training twice weekly for 60 minutes, with three sets of 10 repetitions at 75 percent of one-repetition maximum, 90-second rest intervals, and a 3-0-2-1 tempo. The supervised physiotherapy and home-based arms use developmental position-based exercise emphasizing trunk stabilization, breathing coordination, support, and movement quality. OHMTRACK biofeedback will be used in selected groups to support real-time regulation of intra-abdominal pressure.
Outcome measures will cover pain, trunk muscle function, postural stabilization, body composition, cardiovascular health, respiratory function, metabolic health, strength, functional capacity, adherence, behavioral regulation, and adverse events. Measurements are scheduled at baseline, during the intervention, and through follow-up to examine both immediate and retained effects.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 5
- Model description
- Five parallel groups: supervised resistance training with OHMTRACK, supervised resistance training without OHMTRACK, supervised EDP with OHMTRACK, home-based EDP with OHMTRACK, and active control.
| Arm | Type | Receives |
|---|---|---|
| Supervised resistance training with OHMTRACK | Experimental | Behavioral: Gym settingsParticipants complete a 2-week supervised familiarization phase followed by 8 weeks of supervised full-body agonist-antagonist paired set resistance training twice weekly for 60 minutes in the gym setting. Training load is based on 75 percent of 1RM, with three sets of 10 repetitions, 90-second rest intervals, and a 3-0-2-1 tempo. Real-time OHMTRACK biofeedback is used to support breathing mechanics and trunk stabilization. |
| Supervised resistance training without OHMTRACK | Experimental | Behavioral: Gym settingsParticipants complete the same supervised gym-based resistance training program as the OHMTRACK resistance training arm, but without real-time intra-abdominal pressure biofeedback. |
| Supervised EDP with OHMTRACK | Experimental | Behavioral: Physio settingsParticipants complete a 2-week supervised familiarization phase followed by 8 weeks of supervised developmental position-based exercise twice weekly for 60 minutes in the physiotherapy setting. Sessions emphasize movement quality, breathing coordination, support, movement phases, deep trunk stabilization, and real-time intra-abdominal pressure regulation. |
| Home-based EDP with OHMTRACK | Experimental | Behavioral: Home - based settings: exercises based on developmental positionsParticipants complete a 2-week familiarization phase using electronic instructions, manuals, and video recordings, followed by 8 weeks of home-based developmental position-based exercise twice weekly for 60 minutes. Participants may contact the research team with questions. Real-time OHMTRACK biofeedback is used to support self-correction and breathing coordination. |
| Active control | Active comparator | Behavioral: Home - based settings: Usual activity monitoringProposed wording based on the source protocol: participants continue their usual daily activities and wear a Fitbit Inspire 2 for step monitoring, without a structured resistance training or developmental exercise program. This description should be confirmed or replaced if the control condition includes additional procedures. |
Who may qualify
- Ages
- 40 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Chronic low back pain lasting more than 12 weeks, with current low back pain at screening/baseline.
- Resting blood pressure below 139/89 mmHg.
- Health status allowing participation in moderate-intensity resistance training and aerobic activity.
- Physically active, but not professional athletes.
- Non-smoker.
Key exclusion criteria (12 listed)
- Absolute or relative contraindications to resistance training or other clinically relevant cardiovascular contraindications.
- Coronary artery disease, heart rhythm disorders, acute myocarditis, Marfan syndrome, or other cardiovascular conditions judged unsafe by the study physician.
- History of myocardial infarction, cerebrovascular disease, peripheral vascular disease, or grade II-IV hypertension.
- Type 1 or type 2 diabetes mellitus.
- Severe obesity (BMI >= 40.0 kg/m2).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Gym settingsAlso: Agonist-antagonist paired set resistance training with OHMTRACKAn 8-week supervised full-body resistance training program preceded by a 2-week familiarization phase (4 sessions). During the intervention phase, participants perform training twice weekly for 60 minutes per session. Each session includes a 10-minute warm-up, 40-minute main phase, and 10-minute cool-down. The program consists of 3 sets of 10 repetitions at 75% of 1RM, 90-second rest intervals, and a 3-0-2-1 movement tempo. Training is delivered in a gym setting under professional supervision. Resistance training with or without real-time OHMTRACK biofeedback monitor which support breathing mechanics and trunk stabilization. | Behavioural | Supervised resistance training with OHMTRACK, Supervised resistance training without OHMTRACK |
| Physio settingsAn 8-week supervised exercise program based on developmental positions and neurophysiological principles, preceded by a 2-week familiarization phase (4 sessions). Participants exercise twice weekly for 60 minutes per session under physiotherapist supervision. Sessions focus on breathing coordination, deep trunk stabilization, postural control, support function, and movement quality using structured developmental movement sequences. | Behavioural | Supervised EDP with OHMTRACK |
| Home - based settings: exercises based on developmental positionsAlso: Exercises based on developmental positionsAn 8-week home-based exercise program based on developmental positions and neurophysiological principles, preceded by a 2-week familiarization phase (4 sessions). Participants perform exercises twice weekly for 60 minutes per session using electronic manuals and video instructions. The program emphasizes breathing coordination, deep trunk stabilization, postural control, and self-correction of movement quality in an unsupervised home setting, with the possibility of contacting the research team for support. | Behavioural | Home-based EDP with OHMTRACK |
| Home - based settings: Usual activity monitoringAlso: Usual activity monitoringParticipants continue their usual daily activities without participating in a structured resistance training or developmental position exercise program. Physical activity is monitored throughout the study using a wearable activity tracker to record daily step counts and overall movement behavior. | Behavioural | Active control |
Primary outcome
Change in Trunk Flexor and Extensor Muscle Function
Time frame: Baseline, Week 8, Week 12, and Week 16
Trunk Flexor Muscle Strength (Isokinetic Peak Torque): Trunk flexor muscle function will be assessed using an isokinetic dynamometer (Cybex NORM or HUMAC NORM system). The primary outcome will be peak torque during trunk flexion, reported in Newton-meters (N·m) (and, if applicable, normalized to body mass as N·m/kg). Higher values indicate greater trunk flexor strength. Trunk Extensor Muscle Strength (Isokinetic Peak Torque): Trunk extensor muscle function will be assessed using an isokinetic dynamometer (Cybex NORM or HUMAC NORM system). The primary outcome will be peak torque during trunk extension, reported in N·m (and, if applicable, normalized to body mass as N·m/kg). Higher values indicate greater trunk extensor strength.
Short-Form McGill Pain Questionnaire (SF-MPQ) Total Score
Time frame: Baseline to Week 16 (1x every week)
Pain intensity and pain-related characteristics will be assessed using the Short-Form McGill Pain Questionnaire (SF-MPQ). The outcome will be the SF-MPQ total score, calculated as the sum of 15 descriptor items rated on a 0-3 scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). Total score ranges from 0 to 45 points, with higher scores indicating worse pain and lower scores indicating improvement.
Change in DNS-Based Functional Postural Stabilization Performance
Time frame: Baseline, Week 8, Week 12, and Week 16
Abdominal wall tension will be measured during the performance of standardized DNS functional tests using a wearable abdominal wall tension monitoring belt (OHMBelt). The device provides continuous, noninvasive, device-derived estimates of abdominal wall tension, which are related to changes in intra-abdominal pressure. Outcomes will include peak abdominal wall tension and mean abdominal wall tension recorded during each DNS test, reported in device-derived units (arbitrary units, a.u.) (and/or as change from baseline, as applicable). Higher values indicate greater abdominal wall tension during task performance.
18 secondary outcomes
Maximal Oxygen Uptake (VO2max) During Treadmill Graded Exercise Test
Time frame: Baseline, Week 8, Week 12, and Week 16
Quantitative Sensory Testing - Pressure Pain Threshold
Time frame: Baseline, Week 8, Week 12, and Week 16
Isometric Mid-Thigh Pull
Time frame: Baseline, Week 8, Week 12, and Week 16
Handgrip Strength
Time frame: Baseline, Week 8, Week 12, and Week 16
Behavioral Regulation in Exercise Questionnaire (BREQ-3) Subscale Scores
Time frame: Baseline and Week 8
Adverse Events (AEs) and Serious Adverse Events (SAEs)
Time frame: Throughout the intervention period, Weeks 1-8 (every week)
Body Mass Index (BMI)
Time frame: Baseline, Week 8, Week 12, and Week 16
Total Body Fat Mass
Time frame: Baseline, Week 8, Week 12, and Week 16
Lean mass
Time frame: Baseline, Week 8, Week 12, and Week 16
Body Weight
Time frame: Baseline, Week 8, Week 12, and Week 16
Serum Total Cholesterol Concentration
Time frame: Baseline, Week 8, Week 12, and Week 16
Serum Low-Density Lipoprotein (LDL) Cholesterol Concentration
Time frame: Baseline, Week 8, Week 12, and Week 16
Serum High-Density Lipoprotein (HDL) Cholesterol Concentration
Time frame: Baseline, Week 8, Week 12, and Week 16
Fasting Blood Glucose Concentration
Time frame: Baseline, Week 8, Week 12, and Week 16
Systolic Blood Pressure (SBP)
Time frame: Baseline, Week 8, Week 12, and Week 16
Diastolic Blood Pressure (DBP)
Time frame: Baseline, Week 8, Week 12, and Week 16
Aortic Pulse Wave Velocity (aPWV)
Time frame: Baseline, Week 8, Week 12, and Week 16
Resting Heart Rate (RHR)
Time frame: Baseline, Week 8, Week 12, and Week 16
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Mar 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Chronic Low-back Pain (cLBP)
Not yet recruiting
Empowering Pain Psychology Access and Collaboration (EPPAC) to Improve Treatment Engagement Among Medicaid-insured Adults With Chronic Low Back Pain
Chronic Low Back Pain (CLBP)
Not yet recruitingPhase 2
Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain
Chronic Low Back Pain (CLBP), Physical Therapy
RecruitingObservational study
Exploring Multidimensional Trajectories in People With Low Back Pain
Acute Low Back Pain, Chronic Low Back Pain (CLBP)
Recruiting
PRT for Chronic Low Back Pain
Chronic Low Back Pain (CLBP), Nociplastic Pain
Recruiting
Treatment Validation for Myofascial Pain
Chronic Low-back Pain (cLBP), Myofacial Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Gym settings, Physio settings and Home - based settings: exercises based on developmental positions in people with Chronic Low-back Pain (cLBP), run by Charles University, Czech Republic at 1 site in Czechia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 16 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Roman Jurik, Ph.D. (+420 775 218 277, roman.jurik@ftvs.cuni.cz), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Trunk Flexor and Extensor Muscle Function (time frame: Baseline, Week 8, Week 12, and Week 16). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2026.